Abeona Therapeutics
ABEO
#7900
Rank
โ‚น40.42 B
Marketcap
โ‚น709.32
Share price
2.90%
Change (1 day)
28.84%
Change (1 year)

Revenue for Abeona Therapeutics (ABEO)

Revenue in 2026 (TTM): โ‚น1.33 Billion

According to Abeona Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น1.38 Billion. In 2025 the company made a revenue of โ‚น0.52 Billion an increase over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Abeona Therapeutics from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น1.33 B155.72%
2025 โ‚น0.52 B
2024 N/A-100%
2023 โ‚น0.29 B149.02%
2022 โ‚น0.11 B-47.6%
2021 โ‚น0.22 B-69.47%
2020 โ‚น0.73 B
2019 N/A-100%
2018 โ‚น27.12 M-49.24%
2017 โ‚น53.44 M-11.54%
2016 โ‚น60.41 M-12.59%
2015 โ‚น69.11 M17.89%
2014 โ‚น58.62 M-53.53%
2013 โ‚น0.12 B-47.68%
2012 โ‚น0.24 B146.79%
2011 โ‚น97.7 M353.32%
2010 โ‚น21.55 M31.97%
2009 โ‚น16.33 M16.77%
2008 โ‚น13.98 M
2004 โ‚น23.77 M-59.68%
2003 โ‚น58.96 M7.2%
2002 โ‚น55 M369.11%
2001 โ‚น11.72 M
1999 โ‚น0.73 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Merck
MRK
โ‚น6.261 T 452,224.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
โ‚น58.15 B 4,101.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel